USANA Health Sciences, Inc. (USNA) Misses Q2 EPS by 14c
Get Alerts USNA Hot Sheet
Revenue Growth %: -9.9%
Financial Fact:
Income taxes: 6M
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
USANA Health Sciences, Inc. (NYSE: USNA) reported Q2 EPS of $1.36, $0.14 worse than the analyst estimate of $1.50. Revenue for the quarter came in at $188.3 million versus the consensus estimate of $198.3 million.
“USANA generated solid results during the second quarter, notwithstanding several factors that created a challenging year-over-year comparable,” said Dave Wentz, USANA’s Chief Executive Officer. “In 2013, we made a number of important changes to our business, including world-wide policy changes, enhancements to our Associate compensation plan and pricing initiatives. These changes have improved our core business by generating double digit year-over-year increases in our customer counts, Auto Order sales and check earners. As we anticipated and previously communicated, these changes have also created tough year-over-year comparables in 2014 and have caused our financial results to trail our operational progress. As we execute our 2014 strategies, we are confident that our performance will continue to accelerate during the second half of the year and we will deliver another year of record results in 2014. We are also committed to returning value to shareholders through our share repurchase program.”
For earnings history and earnings-related data on USANA Health Sciences, Inc. (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nanometrics (NANO) Issues Business Update, Reports FY23 Results
- ATN International (ATNI) Misses Q1 EPS by 46c ; Offers Guidance
- Ball Corporation (BALL) Raises Dividend, Enters 40M Share Buyback, Announces Management Changes
Create E-mail Alert Related Categories
Earnings, Management CommentsRelated Entities
Stock Buyback, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!